Try our Advanced Search for more refined results

Haverhill Retirement System v. Impax Laboratories, Inc., et al

Track this case

Case Number:

3:13-cv-01566

Court:

California Northern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Firms

Companies

Impax Laboratories, Inc.

Sectors & Industries:

Healthcare
- Major

February 20, 2015
Impax To Settle Investors' Quality-Control Suit For $8M

Impax Laboratories Inc. has reached an $8 million settlement with a class of shareholders who allege that the company downplayed U.S. Food and Drug Administration concerns over quality control at a California plant, it was announced Friday.
July 29, 2014
FDA Faults Impax Quality In Latest Blow To Rytary Approval

Impax Laboratories Inc. on Tuesday disclosed the U.S. Food and Drug Administration's objections to extensive quality lapses at a Taiwan manufacturing plant for its proposed Parkinson's disease medication Rytary, adding to previous production woes that have fueled investor lawsuits over lengthy delays of the drug.
April 09, 2013
Impax Misled Investors About Manufacturing Issues, Suit Says

Impax Laboratories Inc. was hit with a proposed class action in California federal court Monday, accusing it of misleading investors about poor conditions at one of its manufacturing plants, delaying approval for two proposed drugs and causing its stock to trade at inflated prices.